GE HealthCare Technologies Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Peter J. Arduini
- Full Time Employees
- 54,000
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- 500 West Monroe Street Chicago IL United States of America 60661
- IPO Date
- Dec 15, 2022
- CIK
- 0001932393
- Website
- gehealthcare.com
- Similar Companies
- Business
- GE HealthCare Technologies Inc. specializes in the design, production, and global distribution of advanced products, extensive services, and integrated digital platforms aimed at patient diagnostics, therapeutic interventions, and ongoing monitoring across numerous international regions. The organization structures its operations into four distinct divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division delivers sophisticated molecular imaging, computed tomography (CT), magnetic resonance (MR), image-guided therapy, and X-ray systems, alongside specialized offerings for women's health screening. The Ultrasound division offers solutions for the detection, assessment, treatment, and continuous oversight of various conditions through applications in radiology, primary care, cardiovascular health, women’s health, and handheld point-of-care devices, also incorporating surgical visualization and guidance products with AI-enabled productivity tools. The Patient Care Solutions division is dedicated to furnishing medical devices, essential consumables, supportive services, and intelligent digital tools for patient monitoring, anesthesia delivery and respiratory management, diagnostic cardiology, and maternal and infant care. The Pharmaceutical Diagnostics division supplies a range of diagnostic agents, including contrast media for CT, angiography, X-ray, and MR scans, as well as single-photon emission computed tomography and positron emission tomography, to the radiology and nuclear medicine sectors. This segment also provides pharmaceuticals administered prior to imaging to enhance tissue visibility and molecular imaging agents, which are radiopharmaceuticals with radioisotopes used for diagnostic scans. The company was established as a corporate entity in 2022 and maintains its primary corporate offices in Chicago, Illinois. In a significant recent development, the company has agreed to acquire Intelerad, a medical imaging software provider, for $2.3 billion, a move set to substantially enhance its cloud-based and AI-enabled imaging solutions, particularly expanding its reach into outpatient and teleradiology markets. This acquisition is expected to accelerate GE HealthCare's transition to a software-as-a-service (SaaS) business model and significantly boost its recurring revenue.
GEHC Stock Up on $500M Strategic Care Alliance With Catholic Health
Catholic Health and GE HealthCare partner to expand patient access across Long Island
Do Options Traders Know Something About GE HealthCare Stock We Don't?
GE HealthCare & Mayo Clinic Unite to Advance Cancer Theranostics
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
GE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration
GE HealthCare Technologies Inc. (GEHC) Shareholders Who Lost Money - Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
GE HealthCare to announce second quarter 2026 results on July 29, 2026
Securities Fraud Investigation Into GE HealthCare Technologies Inc. (GEHC) Continues - Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
GE HealthCare announces cash dividend for second quarter of 2026
GEHC Launches Allia Upgrade Pathways for Interventional Suites
GE HealthCare introduces Allia upgrade pathways designed to modernize existing interventional suites
Here Are Tuesday's Best Wall Street Analyst Research Calls: Centene, Darden Restaurants, Flutter Entertainment, GE Healthcare, IBM, Nike, SpaceX, Synopsys, Target, and More
GEHC Expands Carilion Tie to Enhance Patient Care Across Virginia
GE HealthCare advancing enterprise imaging with cloud-enabled solutions
GE HealthCare Gains FDA Clearance for AI Radiation Planning Software
GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
GE HealthCare Technologies Inc. (GEHC) Presents at Jefferies Global Healthcare Conference 2026 Transcript
GE HealthCare Focuses on Expanding Access to Nuclear Medicine Through AI, Radiopharmaceutical and Imaging Innovations
GE HealthCare Technologies: Doing Some Bottom Fishing